Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

被引:753
作者
Smith, Colette J. [1 ]
Ryom, Lene [2 ]
Weber, Rainer [3 ]
Morlat, Philippe [4 ]
Pradier, Christian [5 ]
Reiss, Peter [6 ,7 ]
Kowalska, Justyna D. [8 ]
de Wit, Stephane [9 ]
Law, Matthew [10 ]
el Sadr, Wafaa [11 ]
Kirk, Ole [2 ]
Friis-Moller, Nina [12 ]
Monforte, Antonella d'Arminio [13 ]
Phillips, Andrew N. [1 ]
Sabin, Caroline A. [1 ]
Lundgren, Jens D. [2 ]
机构
[1] UCL, Res Dept Infect & Populat Hlth, London NW3 2PF, England
[2] Univ Copenhagen, Rigshosp, CHIP, Dept Infect Dis 2100, DK-1168 Copenhagen, Denmark
[3] Univ Zurich, Univ Zurich Hosp, Div Infect Dis, Zurich, Switzerland
[4] Univ Bordeaux Segalen, CHU Bordeaux, Serv Med Intern & Malad Infect, Bordeaux, France
[5] Nice Univ Hosp, Dept Publ Hlth, Nice, France
[6] Univ Amsterdam, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands
[7] Stichting HIV Monitoring, Amsterdam, Netherlands
[8] Med Univ Warsaw, Dept Adults Infect Dis, Warsaw, Poland
[9] Hop Univ St Pierre, Dept Infect Dis, B-1000 Brussels, Belgium
[10] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia
[11] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA
[12] Odense Univ Hosp, Dept Infect Dis, Odense, Denmark
[13] San Paolo Univ Hosp, Dept Hlth Sci, Milan, Italy
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; AIDS-DEFINING CANCERS; ANTIRETROVIRAL THERAPY; MYOCARDIAL-INFARCTION; DATA-COLLECTION; ADVERSE EVENTS; RISK-FACTORS; HEPATITIS-C; MORTALITY; INFECTION;
D O I
10.1016/S0140-6736(14)60604-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background With the advent of effective antiretroviral treatment, the life expectancy for people with HIV is now approaching that seen in the general population. Consequently, the relative importance of other traditionally non-AIDS-related morbidities has increased. We investigated trends over time in all-cause mortality and for specific causes of death in people with HIV from 1999 to 2011. Methods Individuals from the Data collection on Adverse events of anti-HIV Drugs (D: A: D) study were followed up from March, 1999, until death, loss to follow-up, or Feb 1, 2011, whichever occurred first. The D: A: D study is a collaboration of 11 cohort studies following HIV-1-positive individuals receiving care at 212 clinics in Europe, USA, and Australia. All fatal events were centrally validated at the D: A: D coordinating centre using coding causes of death in HIV (CoDe) methodology. We calculated relative rates using Poisson regression. Findings 3909 of the 49 731 D: A: D study participants died during the 308 719 person-years of follow-up (crude incidence mortality rate, 12 7 per 1000 person-years [95% CI 12.3-13.1]). Leading underlying causes were: AIDS-related (1123 [29%] deaths), non-AIDS-defining cancers (590 [15%] deaths), liver disease (515 [13%] deaths), and cardiovascular disease (436 [11%] deaths). Rates of all-cause death per 1000 person-years decreased from 17 5 in 1999-2000 to 9 1 in 2009-11; we saw similar decreases in death rates per 1000 person-years over the same period for AIDS-related deaths (5 9 to 2 0), deaths from liver disease (2 7 to 0 9), and cardiovascular disease deaths (1 8 to 0 9). However, non-AIDS cancers increased slightly from 1 6 per 1000 person-years in 1999-2000 to 2 1 in 2009-11 (p=0.58). After adjustment for factors that changed over time, including CD4 cell count, we detected no decreases in AIDS-related death rates (relative rate for 2009-11 vs 1999-2000: 0 92 [0.70-1.22]). However, all-cause (0 72 [0.61-0.83]), liver disease (0 48 [0.32-0.74]), and cardiovascular disease (0 33 [0.20-0.53) death rates still decreased over time. The percentage of all deaths that were AIDS-related (87/256 [34%] in 1999-2000 and 141/627 [22%] in 2009-11) and liver-related (40/256 [16%] in 1999-2000 and 64/627 [10%] in 2009-11) decreased over time, whereas non-AIDS cancers increased (24/256 [9%] in 1999-2000 to 142/627 [23%] in 2009-11). Interpretation Recent reductions in rates of AIDS-related deaths are linked with continued improvement in CD4 cell count. We hypothesise that the substantially reduced rates of liver disease and cardiovascular disease deaths over time could be explained by improved use of non-HIV-specific preventive interventions. Non-AIDS cancer is now the leading non-AIDS cause and without any evidence of improvement.
引用
收藏
页码:241 / 248
页数:8
相关论文
共 33 条
  • [11] HIV and Aging: State of Knowledge and Areas of Critical Need for Research. A Report to the NIH Office of AIDS Research by the HIV and Aging Working Group
    High, Kevin P.
    Brennan-Ing, Mark
    Clifford, David B.
    Cohen, Mardge H.
    Currier, Judith
    Deeks, Steven G.
    Deren, Sherry
    Effros, Rita B.
    Gebo, Kelly
    Goronzy, Joerg J.
    Justice, Amy C.
    Landay, Alan
    Levin, Jules
    Miotti, Paolo G.
    Munk, Robert J.
    Nass, Heidi
    Rinaldo, Charles R., Jr.
    Shlipak, Michael G.
    Tracy, Russell
    Valcour, Victor
    Vance, David E.
    Walston, Jeremy D.
    Volberding, Paul
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 60 : S1 - S18
  • [12] Addressing Smoking During Medical Visits Patients with Human Immunodeficiency Virus
    Horvath, Keith J.
    Eastman, Melissa
    Prosser, Rachel
    Goodroad, Brian
    Worthington, Loretta
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2012, 43 (05) : S214 - S221
  • [13] Antiretroviral Drug-Related Liver Mortality Among HIV-Positive Persons in the Absence of Hepatitis B or C Virus Coinfection: The Data Collection on Adverse Events of Anti-HIV Drugs Study
    Kovari, Helen
    Sabin, Caroline A.
    Ledergerber, Bruno
    Ryom, Lene
    Worm, Signe W.
    Smith, Colette
    Phillips, Andrew
    Reiss, Peter
    Fontas, Eric
    Petoumenos, Kathy
    De Wit, StePhane
    Morlat, Philippe
    Lundgren, Jens D.
    Weber, Rainer
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 56 (06) : 870 - 879
  • [14] The Coding Causes of Death in HIV (CoDe) Project Initial Results and Evaluation of Methodology
    Kowalska, Justyna D.
    Friis-Moller, Nina
    Kirk, Ole
    Bannister, Wendy
    Mocroft, Amanda
    Sabin, Caroline
    Reiss, Peter
    Gill, John
    Lewden, Charlotte
    Phillips, Andrew
    Monforte, Antonella D'Arminio
    Law, Matthew
    Sterne, Jonathan
    De Wit, Stephane
    Lundgren, Jens D.
    [J]. EPIDEMIOLOGY, 2011, 22 (04) : 516 - 523
  • [15] Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
    Kuller, Lewis H.
    Tracy, Russell
    Belloso, Waldo
    De Wit, Stephane
    Drummond, Fraser
    Lane, H. Clifford
    Ledergerber, Bruno
    Lundgren, Jens
    Neuhaus, Jacqueline
    Nixon, Daniel
    Paton, Nicholas I.
    Neaton, James D.
    [J]. PLOS MEDICINE, 2008, 5 (10): : 1496 - 1508
  • [16] Smoking-Related Health Risks Among Persons With HIV in the Strategies for Management of Antiretroviral Therapy Clinical Trial
    Lifson, Alan R.
    Neuhaus, Jacqueline
    Ramon Arribas, Jose
    van den Berg-Wolf, Mary
    Labriola, Ann M.
    Read, Timothy R. H.
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2010, 100 (10) : 1896 - 1903
  • [17] Lundgren JD, 2012, 19 INT AIDS C WASH D
  • [18] Projected life expectancy of people with HIV according to timing of diagnosis
    Nakagawa, Fumiyo
    Lodwick, Rebecca K.
    Smith, Colette J.
    Smith, Ruth
    Cambiano, Valentina
    Lundgren, Jens D.
    Delpech, Valerie
    Phillips, Andrew N.
    [J]. AIDS, 2012, 26 (03) : 335 - 343
  • [19] The role of HIV in serious diseases other than AIDS
    Phillips, Andrew N.
    Neaton, James
    Lundgren, Jens D.
    [J]. AIDS, 2008, 22 (18) : 2409 - 2418
  • [20] Pinzone MR, 2012, EUR REV MED PHARMACO, V16, P1377